376 related articles for article (PubMed ID: 30326952)
21. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
[TBL] [Abstract][Full Text] [Related]
22. The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial.
Okebe J; Bousema T; Affara M; DiTanna G; Eziefula AC; Jawara M; Nwakanma D; Amambua-Ngwa A; Van Geertruyden JP; Drakeley C; D'Alessandro U
Trials; 2015 Mar; 16():70. PubMed ID: 25887344
[TBL] [Abstract][Full Text] [Related]
23. The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
Dysoley L; Kim S; Lopes S; Khim N; Bjorges S; Top S; Huch C; Rekol H; Westercamp N; Fukuda MM; Hwang J; Roca-Feltrer A; Mukaka M; Menard D; Taylor WR
BMC Infect Dis; 2019 Mar; 19(1):250. PubMed ID: 30871496
[TBL] [Abstract][Full Text] [Related]
24. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
Dicko A; Brown JM; Diawara H; Baber I; Mahamar A; Soumare HM; Sanogo K; Koita F; Keita S; Traore SF; Chen I; Poirot E; Hwang J; McCulloch C; Lanke K; Pett H; Niemi M; Nosten F; Bousema T; Gosling R
Lancet Infect Dis; 2016 Jun; 16(6):674-684. PubMed ID: 26906747
[TBL] [Abstract][Full Text] [Related]
25. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
Maude RJ; Socheat D; Nguon C; Saroth P; Dara P; Li G; Song J; Yeung S; Dondorp AM; Day NP; White NJ; White LJ
PLoS One; 2012; 7(5):e37166. PubMed ID: 22662135
[TBL] [Abstract][Full Text] [Related]
26. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
Okebe J; Dabira E; Jaiteh F; Mohammed N; Bradley J; Drammeh NF; Bah A; Masunaga Y; Achan J; Muela Ribera J; Yeung S; Balen J; Peeters Grietens K; D'Alessandro U
Malar J; 2021 Jun; 20(1):253. PubMed ID: 34098984
[TBL] [Abstract][Full Text] [Related]
27. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Gerardin J; Eckhoff P; Wenger EA
BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
[TBL] [Abstract][Full Text] [Related]
28. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
Sutanto I; Suprijanto S; Kosasih A; Dahlan MS; Syafruddin D; Kusriastuti R; Hawley WA; Lobo NF; Ter Kuile FO
Clin Infect Dis; 2013 Mar; 56(5):685-93. PubMed ID: 23175563
[TBL] [Abstract][Full Text] [Related]
29. Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area.
Song J; Socheat D; Tan B; Seila S; Xu Y; Ou F; Sokunthea S; Sophorn L; Zhou C; Deng C; Wang Q; Li G
Malar J; 2011 Aug; 10():231. PubMed ID: 21827706
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
31. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
Yukich JO; Scott C; Silumbe K; Larson BA; Bennett A; Finn TP; Hamainza B; Conner RO; Porter TR; Keating J; Steketee RW; Eisele TP; Miller JM
Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):46-53. PubMed ID: 32618249
[TBL] [Abstract][Full Text] [Related]
32. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
[TBL] [Abstract][Full Text] [Related]
33. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Giao PT; de Vries PJ; Hung le Q; Binh TQ; Nam NV; Kager PA
Trop Med Int Health; 2004 Feb; 9(2):209-16. PubMed ID: 15040557
[TBL] [Abstract][Full Text] [Related]
34. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
[TBL] [Abstract][Full Text] [Related]
35. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.
Kwambai TK; Dhabangi A; Idro R; Opoka R; Kariuki S; Samuels AM; Desai M; van Hensbroek MB; John CC; Robberstad B; Wang D; Phiri K; Ter Kuile FO
Trials; 2018 Nov; 19(1):610. PubMed ID: 30400934
[TBL] [Abstract][Full Text] [Related]
36. Eliminating Plasmodium falciparum malaria: results from tailoring active case detection approaches to remote populations in forested border areas in north-eastern Cambodia.
Stratil AS; Vernaeve L; Lopes S; Bourny Y; Mannion K; Hamade P; Roca-Feltrer A; Tibenderana JK; Sovannaroth S; Debackere M
Malar J; 2021 Feb; 20(1):108. PubMed ID: 33618718
[TBL] [Abstract][Full Text] [Related]
37. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
Lwin KM; Phyo AP; Tarning J; Hanpithakpong W; Ashley EA; Lee SJ; Cheah P; Singhasivanon P; White NJ; Lindegårdh N; Nosten F
Antimicrob Agents Chemother; 2012 Mar; 56(3):1571-7. PubMed ID: 22252804
[TBL] [Abstract][Full Text] [Related]
39. Effect of interventions to reduce malaria incidence among military personnel on active duty: study protocol for a cluster randomised controlled trial of the impact of etofenprox-treated uniforms, permethrin-treated uniforms and DEET insect repellent.
Msellemu D; Ross A; Temu L; Moshi I; Hofer L; Mwanziva C; Kohi YM; Moore SJ
Trials; 2021 Nov; 22(1):825. PubMed ID: 34802455
[TBL] [Abstract][Full Text] [Related]
40. Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
Rossi G; Vernaeve L; Van den Bergh R; Nguon C; Debackere M; Abello Peiri C; Van V; Khim N; Kim S; Eam R; Ken M; Khean C; De Smet M; Menard D; Kindermans JM
Clin Infect Dis; 2018 May; 66(10):1610-1617. PubMed ID: 29361021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
